Comparative Pharmacology
Head-to-head clinical analysis: CORTICOTROPIN versus CORTROPHIN ZINC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CORTICOTROPIN versus CORTROPHIN ZINC.
CORTICOTROPIN vs CORTROPHIN-ZINC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Corticotropin (ACTH) stimulates the adrenal cortex to release cortisol, corticosterone, aldosterone, and androgens via activation of melanocortin 2 receptor (MC2R) in the zona fasciculata and reticularis.
Corticotropin (ACTH) stimulates the adrenal cortex to release glucocorticoids, mineralocorticoids, and androgens. In gel formulation, zinc complex prolongs absorption, providing sustained adrenocortical stimulation.
40-80 units IM or SC every 24-72 hours; dose adjusted based on response.
40-80 units subcutaneously or intramuscularly every 24-72 hours, titrated to individual patient response.
None Documented
None Documented
15-30 minutes (intravenous); clinically, duration of action (via adrenal stimulation) exceeds half-life due to sustained cAMP-mediated effects.
Terminal half-life: 16-24 hours; clinical context: prolonged due to zinc complex, allows once-daily dosing
Primarily metabolized in tissues via proteolysis; negligible renal excretion of intact hormone (<5%); urinary metabolites include small peptide fragments.
Renal: ~90% as metabolites; biliary/fecal: ~10%
Category C
Category C
Corticotropin
Corticotropin